Precipio Inc. has launched its pancreatic cancer liquid biopsy kit for pancreatic cancer. The kit is intended to enable a cost of only $100 per specimen, which would be just a fraction of the cost of other tests. That price point could prove reasonable enough to better enable routine monitoring for cancer patients by making it more economically feasible for patients.